Prucalopride for the treatment of chronic constipation in women - guidance (TA211)

National Institute for Health and Care Excellence - NICE
Publication date:
15 December 2010


Evidence-based recommendations on prucalopride (Resolor) for treating chronic constipation in women.

Guidance development process

How we develop NICE technology appraisal guidance

Is this guidance up to date?

We reviewed the evidence in January 2014. We found nothing new that affects the recommendations in this guidance.

Next review: This guidance will be reviewed if there is new evidence that is likely to affect the recommendations.